ReviewFrontiers in oncology2026
Mayo adhesive probability score predicts perioperative outcomes of laparoscopic adrenalectomy: a systematic review and meta-analysis.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This meta-analysis aims to systematically evaluate the association between the Mayo Adhesive Probability (MAP) score and perioperative outcomes of laparoscopic adrenalectomy (LA) for benign adrenal tumors, and to explore the value of the MAP score in preoperative risk stratification. Method: A comprehensive literature search was conducted in Embase, PubMed, Cochrane Library, and Web of Science from inception to June 1, 2025, to identify studies investigating the correlation between MAP score and LA outcomes. Eligible studies were selected based on predefined criteria, and data extraction was performed independently by two reviewers. The primary outcomes included operative time (OT), estimated blood loss (EBL), length of stay (LOS), and postoperative complications. In addition, baseline and clinicopathological characteristics, including body mass index (BMI), gender distribution, hormonal activity, diabetes mellitus history, and hypertension history, were compared between the study-defined higher MAP and lower MAP groups. Meta-analysis was performed using Stata 16.0. Results: A total of 5 retrospective studies involving 578 patients were included. A meta-analysis showed that, compared with the low MAP score group, the high MAP score group had significantly longer OT, higher EBL, and a higher risk of complications. No significant difference in LOS was observed between the two groups. Additionally, the high MAP score group had a higher BMI, a higher proportion of male patients, and more frequent hormonal activity. There were no significant differences in the history of diabetes mellitus or hypertension between the groups. Conclusions: Higher MAP scores were associated with longer operative time, greater estimated blood loss, and a higher complication rate in laparoscopic adrenalectomy, while no significant difference in length of stay was observed. The MAP score may be a useful adjunct for preoperative risk assessment, although prospective validation is still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.